INTRODUCTION
============

Cushing\'s syndrome is a disorder caused by excess cortisol and can result in clinical manifestations including obesity, hypertension, diminished glucose intolerance, sexual and menstrual dysfunction, hirsutism, acne, striae, emotional liability, and osteoporosis.^[@B1]^ Most cases (80%) of endogenous Cushing\'s syndrome are caused by a pituitary adenoma (ie, Cushing\'s disease), 10% by ectopic production of ACTH, 5% by adrenal adenoma, and 5% by carcinoma.^[@B2]^ In the United States, the annual incidence of endogenous Cushing\'s syndrome has been estimated at 13 cases per one million individuals.

Select patients with ACTH-dependent Cushing\'s syndrome, such as patients with persistent Cushing\'s disease after failed hypophysectomy or patients with ectopic ACTH production, may ultimately require bilateral adrenalectomy. Other rare indications for bilateral adrenalectomy include adrenocortical hyperplasia, bilateral adrenocortical adenomas, congenital adrenal hyperplasia, and bilateral pheochromocytomas in patients with multiple endocrine neoplasia type 2 or von Hippel-Lindau syndrome. Although laparoscopic surgery is the standard of care for most adrenal tumors, concurrent bilateral laparoscopic adrenalectomy is less established. To date, only 6 published series with more than 15 patients exist. We report on the first synchronous bilateral adrenalectomy utilizing a robotic approach and provide a brief review of the literature regarding the role of minimally invasive surgery for this procedure.

CASE REPORT
===========

A 45-year-old Caucasian female with hypercortisolism underwent transsphenoidal hypophysectomy for a 4-mm by 5-mm pituitary lesion diagnosed on RI. Postoperatively, she had persistently elevated ACTH and cortisol levels. Comuted tomographic (CT) scan revealed bilateral adrenal hyperplasia without evidence of an ectopic ACTH-producing tumor **([Figure 1](#F1){ref-type="fig"})**. A diagnosis of nonremitting ACTH-dependent hypercortisolism was made. Treatment options were considered including completion hypophysectomy, medical management, and bilateral adrenalectomy with steroid replacement. The patient elected to undergo concurrent robotic-assisted bilateral adrenalectomy.

![Computed tomographic scan of abdomen with contrast revealing bilateral adrenal hyperplasia. No masses or nodules seen.](jsls-12-2-198-g01){#F1}

METHODS
=======

The patient was placed in a left lateral decubitus position. Veress needle pneumoperitoneum was established. Three triangulated robotic ports were placed directed towards the right adrenal gland: a 12-mm camera port and two 8-mm robotic ports as seen in **[Figure 2](#F2){ref-type="fig"}**. A 12-mm periumbilical port and a 5-mm subxiphoid port were placed and used for retraction, suction, and specimen retrieval by the assistant. The robot was docked, and the right adrenal gland was removed in 77 minutes following the standard laparoscopic technique. It was placed in a 10-mm ENDOCATCH bag (US Surgical Corporation, Pembroke, Bermuda), and the string was externalized through the umbilical port.

![Diagram of port placement for right sided robotic adrenalectomy. Patient in left lateral decubitis position. Robot docked over ipsilateral shoulder. Ports 1--3 triangulated toward adrenal bed. For left side, patient rotated and ports 1--3 replaced in similar fashion towards left adrenal gland. Assistant ports 4 and 5 used for right and left adrenalectomy. AAL=anterior axillary line; MCL=midclavicular line; ML=midline.](jsls-12-2-198-g02){#F2}

The robot was dedocked, and the patient was rotated into a right lateral decubitus position. A 12-mm port was reinserted through the umbilical incision, and the abdomen was insufflated to 20 mm Hg. In a similar fashion, a 12-mm port and two 8-mm robotic ports were placed in an isosceles triangle directed towards the left adrenal gland. The subxiphoid 5-mm port was replaced orthotopically. The robot was redocked. The left adrenal gland was removed in 55 minutes. The specimen was placed in a second 10-mm ENDOCATCH bag, and both specimens were removed through a 4-cm extended umbilical incision. The overall operative time was 235 minutes.

The patient\'s postoperative course was uncomplicated, and she was discharged home on postoperative day 3 on steroid replacement. Histopathologic analysis confirmed mild adrenal hyperplasia. At one-month follow-up, the patient was doing well, and prior stigmata of hypercortisolism have resolved.

DISCUSSION
==========

Transsphenoidal surgery for resection of an ACTH-secreting pituitary tumor is the standard therapy for Cushing\'s disease, but it is associated with a 20% to 40% failure rate.^[@B3]^ Completion hypophysectomy presents an increased risk of panhypopituitarism and may be poorly tolerated. Sellar radiation therapy is not an ideal therapy for Cushing\'s disease because of its delayed onset of action and high remission rates.^[@B4],[@B5]^ Long-term pharmacotherapy can carry significant side effects.^[@B6]^ Therefore, bilateral adrenalectomy may be an alternative therapy in select patients with Cushing\'s disease who fail initial pituitary surgery. Laparoscopic bilateral adrenalectomy has been described and can offer definitive treatment with low morbidity compared with open techniques.^[@B7],[@B8]^ While robotic adrenalectomy has been shown to be a safe and effective alternative to laparoscopic adrenalectomy,^[@B9]^ no published reports have been published on synchronous robotic bilateral adrenalectomy.

A review of 118 laparoscopic bilateral adrenalectomies from 6 published series is presented in **[Table 1](#T1){ref-type="table"}**.^[@B9]--[@B15]^ Our robotic bilateral adrenalectomy was performed in 235 minutes with 132 minutes of operative console time and a 50 mL estimated blood loss. The procedure was performed without complication or associated patient morbidity.

###### 

Synchronous Laparoscopic Bilateral Adrenalectomy: Review of Published Reports With 15 or More Cases Compared With Our Synchronous Robotic Bilateral Adrenalectomy

  Author                 Diagnosis [\*](#TF1-1){ref-type="table-fn"} (n)   Op Time (min)   Open Conversion   Blood Loss (mL)   Hosp Stay (d)   Postoperative Morbidity and Mortality[\*](#TF1-1){ref-type="table-fn"}
  ---------------------- ------------------------------------------------- --------------- ----------------- ----------------- --------------- ------------------------------------------------------------------------
  Acosta et al^[@B10]^   CS (17)                                           360             1                 N/A               6               Hypoglycemia (1) Back pain (1) Death from GI bleed (1)
  Bonjer et al^[@B11]^   CS (13) Pheo (3)                                  214             1                 121               5               Hematoma (1) UTI (1) Death from sepsis (1)
  Vella et al^[@B12]^    CS (19)                                           252             3                 N/A               2.7             DVT (1)
  Hawn et al^[@B13]^     CS (18)                                           296             None              218               3               Hemorrhage (1) Pancreatitis (1)
  Jager et al^[@B14]^    CS (16) Pheo (2)                                  289             None              125               7               Death from PE (1)
  Takata et al^[@B15]^   CS (25) Pheo (5)                                  290             None              81                3.5             UTI (2) Pneumonia (1) Addisonian crisis (1) Wd infection (1) DI (1)
  Summary                CS (108) Pheo (10)                                284             4.2%              136               4.5             14% morbidity 2.5% mortality
  Present Case           Persistent Hypercortisolism                       132 (console)   None              50                3               None

CS = Cushing\'s syndrome, Pheo = pheochromocytoma, UTI = urinary tract infection, DVT = deep venous thrombosis, DI = diabetes insipidus.

Our first experience with bilateral robotic adrenalectomy was performed with less blood loss, shorter hospital stay, shorter operative time, and no complications, compared with the data from published laparoscopic series **([Table 1](#T1){ref-type="table"})**. These early data are encouraging, and we will continue to refine our technique and we hope improve operative and perioperative parameters.

CONCLUSION
==========

Robotic-assisted synchronous bilateral adrenalectomy is a feasible and safe procedure. Preoperative and perioperative parameters appear equivalent and potentially superior to parameters in larger published laparoscopic series. A larger experience with longer follow-up will be necessary to further assess this novel approach.
